RECOVER will address the most pressing issues for patients and health policy. Medical research will provide clear insight into the nature of the virus and determine the best approach to preventing further spread of the disease. RECOVER will thus provide scientific knowledge that can be used by clinical experts, health authorities and policy makers to protect public health and save lives. The RECOVER project is complementary to studies currently being conducted in China and other parts of the world.
"We are very grateful that the European Union supports initiatives that address this new outbreak,” says Herman Goossens, coordinator of RECOVER and professor at the University of Antwerp. "We look forward to working with our European and Chinese partners to deepen our knowledge of this disease and thus save lives."
The RECOVER consortium consists of international partners, the European Commission, the European Centre for Disease Prevention and Control (ECDC) as well as the European Medicines Agency (EMA). It has agreed on a number of urgent next steps, including:
a study on the experiences of EU citizens with COVID-19 and the impact of this disease;
a study aiming to understand the transmission of the virus within families and the impact of interventions to reduce it;
a study examining whether and how children can contribute to the spread of the virus;
recommendations to the EU to protect the health of those involved in the fight against the virus.
The results of all RECOVER studies will concretely guide the European response to COVID-19.